BeStock  
Stocks › Medical Devices › DCTH

Delcath Systems DCTH

US equityMarket cap rank #3435Medical Devices
$18.79 −$0.45 (-2.34%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.50 -1.54%
Open$18.89
Prev close$19.24
Day range$18.51 – $19.35
Volume592.1K
Market cap$653.67M
P/E (TTM)117.4
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership68.3%+16.22 pts vs. prior quarter
Institutions holding164+13 vs. prior quarter
Insider trades (recent)45 buys / 5 sellsNet buying
Short interest5.12% of floatDays to cover 5.7 · as of 30 Oct 2026
Short-sale volume share16.6%5-day average of daily volume

Short-sale volume as % of daily volume

5%15%25%35%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$22.7K (10 inflow days, 10 outflow days).

Net flow by order size, last 20 sessions

−$545.7KSuper+$568.4KBig−$1.7MMid−$1.3MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 41.8% of shares outstanding.

Largest holders

  • Rosalind Advisors, Inc.19.23%
  • BlackRock11.49%
  • Daniel Kaufman5.08%
  • Vanguard Capital Management, LLC3.53%
  • Propel Bio Management, LLC2.51%
  • Geode Capital Management, LLC2.37%
  • State Street Global Advisors2.18%
  • Algert Global LLC1.67%

By investor type

  • Mutual Fund34.35%
  • Hedge Fund29.17%
  • Individual/Insider7.15%
  • Public Company3.91%
  • Government Pension Fund0.33%
  • Private Company0.22%
  • Insurance Company0.19%
  • VC/PE Fund0.12%

Reported short interest has fallen from 6.79% to 5.12% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Rosalind Advisors, Inc. Hedge Fund 2026/Q3 +3,388,475 19.2%
BlackRock Mutual Fund 2026/Q3 +1,289,767 11.5%
Morgan Stanley Public Company 2026/Q3 +142,574 1.6%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +142,574 1.6%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +141,723 1.0%
JPMorgan Chase & Co. Public Company 2026/Q3 +137,595 0.4%
Acadian Asset Management LLC Mutual Fund 2026/Q3 +114,009 0.3%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +104,605 0.9%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +89,786 2.4%
State Street Global Advisors Mutual Fund 2026/Q3 +80,662 2.2%
Franklin Resources Mutual Fund 2026/Q3 +64,906 0.2%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +66,453 0.2%
BlackRock Mutual Fund 2026/Q3 +922,336 7.8%
Algert Global LLC Hedge Fund 2026/Q3 +434,975 1.7%
ExodusPoint Capital Management, LP Hedge Fund 2026/Q3 +323,916 1.0%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
11 Nov 2026 Bridget Martell Director Derivative Exercise and Sale -22,500 $22.26 –
12 Oct 2026 Rosalind Advisors, Inc. Other Disposition -23,875 – 3,276,514
12 Oct 2026 Rosalind Advisors, Inc. Derivative Exercise and Sale -3,627 – 3,276,514
12 May 2026 Elizabeth Czerepak Independent Director Other Derivative Acquisition +22,500 $11.61 22,500
12 May 2026 Steven Salamon Independent Director Other Derivative Acquisition +22,500 $11.61 22,500
12 May 2026 John Sylvester Independent Chairperson Other Derivative Acquisition +22,500 $11.61 22,500
12 May 2026 Gilad Aharon Independent Director Other Derivative Acquisition +22,500 $11.61 22,500
12 May 2026 Bridget Martell Director Other Derivative Acquisition +22,500 $11.61 22,500
5 Mar 2026 Sandra Pennell Chief Financial Officer Open Market Acquisition +5,533 $9.04 77,018
1 Mar 2026 Gerard Michel Chief Executive Officer Open Market Acquisition +11,200 $8.96 342,034
16 Feb 2026 Gerard Michel Chief Executive Officer Other Derivative Acquisition +97,500 – 97,500
16 Feb 2026 Gerard Michel Chief Executive Officer Other Derivative Acquisition +195,000 $9.40 195,000
16 Feb 2026 Vojislav Vukovic Chief Medical Officer Other Derivative Acquisition +28,250 – 28,250
16 Feb 2026 Vojislav Vukovic Chief Medical Officer Other Derivative Acquisition +56,500 $9.40 56,500
16 Feb 2026 Sandra Pennell Chief Financial Officer Other Derivative Acquisition +28,250 – 28,250
16 Feb 2026 Sandra Pennell Chief Financial Officer Other Derivative Acquisition +56,500 $9.40 56,500
16 Feb 2026 Martha Rook Chief Operating Officer Other Derivative Acquisition +28,250 – 28,250
16 Feb 2026 Martha Rook Chief Operating Officer Other Derivative Acquisition +56,500 $9.40 56,500
16 Feb 2026 David Hoffman General Counsel, Corporate Secretary & Chief Compliance Officer Other Derivative Acquisition +28,250 – 28,250
16 Feb 2026 David Hoffman General Counsel, Corporate Secretary & Chief Compliance Officer Other Derivative Acquisition +56,500 $9.40 56,500

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 1,775,571 5.1% 5.7
15 Oct 2026 1,883,018 5.4% 6.2
30 Sep 2026 1,947,041 5.6% 5.4
15 Sep 2026 2,311,774 6.7% 6.9
31 Aug 2026 2,242,281 6.5% 5.0
14 Aug 2026 2,355,057 6.8% 2.3

Discussion

No comments yet — be the first to weigh in on DCTH.

Sign in to join the discussion.

Scroll to Top